PsyBio Therapeutics Announces Application to Listing on OTCQX

OXFORD, Ohio and COCONUT CREEK, Fla., April 12, 2021 /PRNewswire/ — PsyBio Therapeutics Corp. (TSXV:

OXFORD, Ohio and COCONUT CREEK, Fla., April 12, 2021 /PRNewswire/ — PsyBio Therapeutics Corp. (TSXV: PSYB) (“PsyBio” or the “Enterprise“), a biotechnology enterprise groundbreaking the next era of specific psychoactive medicines, is happy to announce that it has submitted an application to have its subordinate voting shares (the “Shares”) listed for investing on the OTCQX® Most effective Marketplace (the “OTCQX“), a United States investing platform that is operated by the OTC Marketplaces Team Inc. in New York. The listing of the Firm’s Shares on the OTCQX continues to be issue to the approval of the OTCQX and the gratification of applicable listing requirements, such as the Firm’s application for Depository Rely on Company (“DTC“) eligibility to empower investing on the OTCQX.

The OTCQX is acknowledged by the U.S. Securities and Trade Fee as an established general public market providing general public information for investigation and price of securities. As a verified current market with productive obtain for U.S. traders, OTCQX aids firms make shareholder price with a aim of enhancing liquidity and attaining a fair valuation.

“We have experienced important desire from U.S. dependent investors in gaining monetary exposure to the rising psychedelics sector, so listing PsyBio on the OTCQX is an important step to give simpler access and investing capability in our Shares for equally institutional and retail traders,” said Evan Levine, CEO of PsyBio. “This will add to 1 of our main methods to boost liquidity, creating on the major progress we have designed about the previous calendar year.”

The Firm’s Shares will go on to trade on the TSX Venture Trade (the “TSXV“) and Frankfurt Inventory Exchange underneath the image “PSYB”.

About OTC Marketplaces Team Inc.

OTC Markets Group Inc. operates the OTCQX® Ideal Marketplace, the OTCQB® Venture Industry and the Pink® Open Sector for 11,000 U.S. and world securities. Via OTC Website link® ATS and OTC Link ECN, PTC Current market Group Inc. connects a various network of broker-dealers that deliver liquidity and execution companies. The company permits traders to quickly trade by means of the broker of their selection and empower providers to enhance the excellent of data obtainable for traders. To learn a lot more about how OTC Marketplaces Group Inc. produces improved informed and much more economical markets, stop by www.otcmarkets.com.

About PsyBio Therapeutics Corp.

PsyBio is a biotechnology organization establishing novel formulations of psychoactive medications created by genetically modified microbes for the cure of psychological well being and other ailments. The group has practical experience in drug discovery based on artificial biology as nicely as medical and regulatory experience moving medications through human scientific tests and regulatory protocols. Exploration and enhancement is now ongoing for in a natural way developing psychoactive tryptamines originally uncovered in unique kinds of hallucinogenic mushrooms, other tryptamines and phenethylamines and mixtures thereof. The Business is also exploring and producing new non-normally developing molecular buildings which may well have unique therapeutics attributes.

Cautionary Be aware About Forward-On the lookout Statements

This push launch includes statements that constitute “ahead-on the lookout information and facts” (“ahead-seeking info“) inside the meaning of the relevant Canadian securities laws. All statements, other than statements of historic truth, are forward-wanting information and are primarily based on anticipations, estimates and projections as at the day of this news launch. Any statement that discusses predictions, anticipations, beliefs, strategies, projections, goals, assumptions, long term gatherings or functionality (typically but not constantly applying phrases these kinds of as “expects”, or “does not count on”, “is envisioned”, “anticipates” or “does not anticipate”, “designs”, “finances”, “scheduled”, “forecasts”, “estimates”, “thinks” or “intends” or versions of such words and phrases and phrases or stating that specific steps, functions or benefits “may possibly” or “could”, “would”, “could” or “will” be taken to occur or be achieved) are not statements of historical truth and may possibly be ahead-on the lookout information. In disclosing the forward-searching information and facts contained in this push launch, the Firm has produced certain assumptions, which includes that: PsyBio will attain DTC eligibility for its Shares PsyBio will be effective in listing its Shares on the OTCQX PsyBio will be profitable in preserving its mental house and submitting new patent programs within the subsequent 12 months PsyBio will be successful in discovering new beneficial goal molecules PsyBio will be prosperous in obtaining Investigation New Drug Purposes and will be ready to get hold of all vital approvals for medical trials PsyBio’s technology will be protected and efficient and that drug enhancement includes extensive direct times, is quite pricey and requires numerous variables of uncertainty. Though the Corporation believes that the expectations mirrored in these kinds of forward-wanting details are reasonable, it can give no assurance that the anticipations of any ahead-looking information and facts will prove to be proper. Identified and unidentified challenges, uncertainties, and other variables which may well cause the genuine results and long term occasions to vary materially from people expressed or implied by these ahead-wanting info. This kind of aspects include things like, but are not confined to: compliance with in depth government rules domestic and foreign rules and restrictions adversely affecting PsyBio’s small business and final results of functions decreases in the prevailing approach for psilocybin and nutraceutical merchandise in the marketplaces in which PsyBio operates the effects of COVID-19 and typical business, financial, competitive, political and social uncertainties. Appropriately, visitors need to not area undue reliance on the forward-hunting data contained in this press launch. Other than as necessary by regulation, the Firm disclaims any intention and assumes no obligation to update or revise any ahead-searching details to mirror true outcomes, regardless of whether as a outcome of new data, future occasions, variations in assumptions, changes in factors affecting these ahead-seeking facts or in any other case.

PsyBio would make no healthcare, therapy or wellbeing reward statements about PsyBio’s proposed products. The U.S. Foodstuff and Drug Administration (the “Food and drug administration“) or other very similar regulatory authorities have not evaluated promises pertaining to psilocybin and other future era psychoactive compounds. The efficacy of such products and solutions have not been verified by Food and drug administration-authorized exploration. There is no assurance that the use of psilocybin and other psychoactive compounds can diagnose, treat, heal or reduce any sickness or affliction. Vigorous scientific exploration and medical trials are desired. PsyBio has not performed scientific trials for the use of its mental property. Any references to high-quality, consistency, efficacy and basic safety of probable solutions do not suggest that PsyBio confirmed these types of in scientific trials or that PsyBio will complete these kinds of trials. If PsyBio are not able to get hold of the approvals or investigation required to commercialize its enterprise, it may possibly have a material adverse impact on the PsyBio’s general performance and operations.

The TSXV has neither authorised nor disapproved the contents of this information launch. Neither the TSXV nor its Regulation Expert services Company (as that time period is outlined in the policies of the TSXV) accepts obligation for the adequacy or precision of this launch.

Resource PsyBio Therapeutics Inc